AU2020101155A4 - Acid-resistant and sustained-release oral crystal ball containing probiotics - Google Patents

Acid-resistant and sustained-release oral crystal ball containing probiotics Download PDF

Info

Publication number
AU2020101155A4
AU2020101155A4 AU2020101155A AU2020101155A AU2020101155A4 AU 2020101155 A4 AU2020101155 A4 AU 2020101155A4 AU 2020101155 A AU2020101155 A AU 2020101155A AU 2020101155 A AU2020101155 A AU 2020101155A AU 2020101155 A4 AU2020101155 A4 AU 2020101155A4
Authority
AU
Australia
Prior art keywords
probiotics
acid
sustained
resistant
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020101155A
Inventor
Se-Chun Liao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Everest Pharm Industrial Co Ltd
Original Assignee
Everest Pharm Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Everest Pharm Industrial Co Ltd filed Critical Everest Pharm Industrial Co Ltd
Priority to AU2020101155A priority Critical patent/AU2020101155A4/en
Application granted granted Critical
Publication of AU2020101155A4 publication Critical patent/AU2020101155A4/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)

Abstract

An acid-resistant and sustained-release oral crystal ball containing probiotics is disclosed herein. It comprises a spherical core for 5 accommodating probiotics, a protection layer wrapped around the spherical core, a sustained-release layer wrapped around the protection layer, a bile salt and pancreatic juice resistant layer wrapped around the sustained-release layer, an acid-resistant layer wrapped around the bile salt and pancreatic juice resistant layer, and an insulation layer wrapped 10 around the acid-resistant layer.

Description

ACID-RESISTANT AND SUSTAINED-RELEASE ORAL CRYSTAL BALL CONTAINING PROBIOTICS
1. Field of the Invention
The present invention relates to an acid-resistant and
sustained-release oral crystal ball containing probiotics which has a
multilayer wrapped structure to improve stability and environmental
tolerance, e.g. acid resistance, bile salt resistance and pancreatic juice
resistance in the digestive tract and can be mass-produced at low cost.
2. Description of Related Art
The stability of probiotics is easily affected by the external
environment, so probiotic products usually have a short shelf life.
Furthermore, after probiotics are taken orally, their activities are
destroyed by gastric acid, bile salts and pancreatic juice in the digestive
tract. As a result, probiotics ingested cannot effectively exert the
expected effects.
In order to solve the abovementioned problems, many
manufacturers use encapsulating technique to process probiotic products.
The conventional method for preparing a final product comprises the
steps of conducting a crushing or sieving processing after probiotics are
encapsulated and freeze-dried, which reduces the integrity of the
encapsulated structure and the protection of probiotics. Furthermore, the currently developed spore probiotics are restricted by spore formation and cannot be universally applied to all probiotic strains. Additionally, products that use microencapsulation to encapsulate crystal balls and dropping pills (e.g. seamless capsules) have the disadvantages of high manufacturing cost and the like due to the particular process technique and manufacturing machines used.
SUMMARY OF THE INVENTION
In view of the above-mentioned problems, the object of the present
invention is to provide an acid-resistant and sustained-release oral crystal
ball containing probiotics which has a multilayer wrapped structure to
improve stability and environmental tolerance, e.g. acid resistance, bile
salt resistance and pancreatic juice resistance in the digestive tract and
can be mass-produced at low cost.
The acid-resistant and sustained-release oral crystal ball containing
probiotics comprises a spherical core for accommodating probiotics; a
protection layer wrapped around the spherical core for providing
probiotics nutrients to prolong and maintain the probiotic activity; a
sustained-release layer wrapped around the protection layer for slow
release of the spherical core; a bile salt and pancreatic juice resistant
layer wrapped around the sustained-release layer for isolating the
spherical core from outside and resisting to bile salt and pancreatic juice; an acid-resistant layer wrapped around the bile salt and pancreatic juice resistant layer for protecting probiotics from gastric acid damage to improve the survival rate and availability of probiotics in the gastrointestinal tract; and an insulation layer wrapped around the acid-resistant layer for protecting the crystal ball from the external environment.
The order of setting the layers of the present invention is based on
the order in which the crystal ball contacts the digestive fluid after
entering the human digestive system. Therefore, the present invention
can effectively protect the spherical core containing probiotics from the
external environment to improve the stability of storage, and reduce the
influence of temperature, pH value, moisture, oxidation or other
substances on probiotics.
Additionally, the multilayer wrapped structure allows slow and
controlled release of probiotics in the digestive tract and avoids the loss
of activity of probiotics due to gastric acid, bile salts and pancreatic juice,
which increase the survival rate and availability of probiotics in the
intestines.
Therefore, the present invention ensures that probiotics in the oral
crystal ball successfully pass through the stomach, intestines and the like,
and improves the survival time of probiotics in the intestines, so as to
effectively provide health care for the intestines.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a stereogram showing an acid-resistant and
sustained-release oral crystal ball containing probiotics according to the
present invention;
FIG. 2 is a sectional view showing an acid-resistant and
sustained-release oral crystal ball containing probiotics according to the
present invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
Hereinafter, an exemplary embodiment of the present invention
will be described in detail with reference to the accompanying drawings.
As showed in FIG. 1 and FIG. 2, an aid-resistant and
sustained-release oral crystal ball containing probiotics is disclosed
herein. It comprises a spherical core (1) for accommodating probiotics, a
protection layer (2) wrapped around the spherical core (1), a
sustained-release layer (3) wrapped around the protection layer (2), a bile
salt and pancreatic juice resistant layer (4) wrapped around the
sustained-release layer (3), an acid-resistant layer (5) wrapped around
the bile salt and pancreatic juice resistant layer (4), and an insulation
layer (6) wrapped around the acid-resistant layer (5).
The spherical core (1) accommodates one kind of probiotic or a
combination of many kinds of probiotics and is made of one or several
substances, e.g. including but not limited to the group consisting of
trehalose, lactose, sucrose, inulin, anhydrous glucose, maltodextrin,
mannitol, sorbitol, xylitol, erythritol, starch and cellulose. Due to the
spherical smooth structure of the spherical core (1), the subsequent
wrapping operation can be performed more easily.
The protection layer (2) is wrapped around the spherical core (1)
and made of one or several substances, e.g. including but not limited to
the group consisting of fructooligosaccharides, xylooligosaccharides,
isomaltooligosaccharides, galactooligosaccharides, raffinose and
oligosaccharides, so as to provide probiotics nutrients to prolong and
maintain the probiotic activity.
The sustained-release layer (3) is wrapped around the protection
layer (2) and made of one or several substances, e.g. including but not
limited to the group consisting of methyl cellulose, hydroxypropyl
cellulose, hydroxypropyl methyl cellulose, sodium carboxymethyl
cellulose, polymethacrylate, ethylene-vinyl acetate copolymer and ethyl
cellulose. Accordingly, the sustained-release layer (3) has a combination
of controlled release film wrapping materials, which can slowly release
probiotics accommodated in the spherical core (1).
The bile salt and pancreatic juice resistant layer (4) is wrapped
around the sustained-release layer (3) and made of one or several substances, e.g. including but not limited to the group consisting of gum arabic, red algae gum, calcium alginate, sodium alginate, agar, tragacanth gum, carrageenan, pectin, locust bean gum, xanthan gum and gelatin. Accordingly, the bile salt and pancreatic juice resistant layer (4) has a combination of colloidal wrapping materials, which can effectively provide the spherical core (1) from outside and has the effect of resistance to bile salts and pancreatic juice.
The acid-resistant layer (5) is wrapped around the bile salt and pancreatic juice resistant layer (4) and made of one or several substances,
e.g. including but not limited to the group consisting of shellac, casein, glycoprotein, whey protein, zein, soy protein, skimmed milk powder, starch acetate, peptide, chitin and chitosan. Accordingly, the
acid-resistant layer (5) includes a combination of protein materials,
which can protect probiotics from gastric acid damage and improve the survival rate and availability of probiotics in the gastrointestinal tract.
The insulation layer (6) is wrapped around the acid-resistant layer
(5) and made of one or several substances, e.g. including but not limited to the group consisting of hydroxypropyl cellulose, hydroxypropyl
methyl cellulose, polyvinylpyrrolidone, polyvinyl alcohol and ethyl
cellulose. Furthermore, the insulation layer (6) can be selectively added with one or several water repellent substances, e.g. including but not
limited to the group consisting of stearic acid, magnesium stearate,
calcium stearate, talcum, silicon dioxide, microcrystalline cellulose and starch. The insulation layer (6) can also be selectively added with colorant, spices or sweetener commonly used in food, e.g. including but not limited to the group consisting of sucralose, neotame, aspartame, saccharin, stevioside, acesulfame potassium and glycyrrhizin, so as to reduce unpleasant taste that may be produced by other layers. Therefore, the insulation layer (6) can protect the crystal ball from the external environment.
According to the structural design of the present invention, the
spherical core (1) can be effectively protected and blocked from the
external environment, so it can greatly reduce the effects of temperature,
pH value, moisture, oxidation or other substances on probiotics and
improve environmental tolerance and stability during storage.
Furthermore, the order of setting the layers of the present invention is
based on the order in which the crystal ball contacts the digestive fluid
after entering the human digestive system. Therefore, the present
invention ensures that probiotics in the oral crystal ball successfully pass
through the stomach, intestines and the like and is controlled released by
various layers with different characteristics so as to avoid the loss of
activity due to gastric acid, bile salts and pancreatic juice and increase
the survival rate and availability of probiotics in the intestines.
Accordingly, the present invention effectively provides health care
for the intestine, changes intestinal flora, inhibits the growth of harmful
bacteria, and promotes intestinal peristalsis, helps digestion and smooth bowel movements, and thereby achieves the effects of regulating physiological functions, promoting metabolism, adjusting physical fitness, reducing allergies and the like. Furthermore, the present invention has simple manufacturing process, low manufacturing cost, so it is easily mass-produced and can be provided for consumers universally. According to the above description, in comparison with the traditional technique, the present invention has the advantages as following:
1. The order of setting the layers of the present invention is based
on the order in which the crystal ball contacts the digestive fluid after entering the human digestive system, which ensures that probiotics in the
oral crystal ball successfully pass through the stomach, intestines and the
like and improves the survival time of probiotics in the intestines, so as to effectively provide health care for the intestines.
2. The multilayer wrapped structure of the present invention
effectively protects the spherical core from the external environment and reduces the influence of temperature, pH value, moisture, oxidation or
other substances on probiotics. Therefore, the environmental tolerance
and the stability of storage of probiotics are improved. 3. The present has the protection layer for providing probiotics
nutrients, the sustained-release layer for slow release of probiotics, the
bile salt and pancreatic juice resistant layer for resisting to bile salt and pancreatic juice, the acid-resistant layer for protecting probiotics from gastric acid damage and the insulation layer for protecting the crystal ball from the external environment, which avoids the loss of activity of probiotics due to gastric acid, bile salts and pancreatic juice, and thus the survival rate and availability of probiotics in the intestines are increased.
4. The present invention has simple manufacturing process, low
manufacturing cost, so it is easily mass-produced and can be provided
for consumers universally.

Claims (1)

WHAT IS CLAIMED IS:
1. An acid-resistant and sustained-release oral crystal ball
containing probiotics, comprising:
a spherical core for accommodating probiotics;
a protection layer wrapped around the spherical core;
a sustained-release layer wrapped around the protection layer;
a bile salt and pancreatic juice resistant layer wrapped around
the sustained-release layer;
an acid-resistant layer wrapped around the bile salt and
pancreatic juice resistant layer; and
an insulation layer wrapped around the acid-resistant layer.
AU2020101155A 2020-06-26 2020-06-26 Acid-resistant and sustained-release oral crystal ball containing probiotics Active AU2020101155A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2020101155A AU2020101155A4 (en) 2020-06-26 2020-06-26 Acid-resistant and sustained-release oral crystal ball containing probiotics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2020101155A AU2020101155A4 (en) 2020-06-26 2020-06-26 Acid-resistant and sustained-release oral crystal ball containing probiotics

Publications (1)

Publication Number Publication Date
AU2020101155A4 true AU2020101155A4 (en) 2020-07-30

Family

ID=71738656

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020101155A Active AU2020101155A4 (en) 2020-06-26 2020-06-26 Acid-resistant and sustained-release oral crystal ball containing probiotics

Country Status (1)

Country Link
AU (1) AU2020101155A4 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112715948A (en) * 2020-12-17 2021-04-30 新希望乳业股份有限公司 High-activity probiotic crystal ball and preparation method and application thereof
CN113521110A (en) * 2021-07-12 2021-10-22 深圳零一生命科技有限责任公司 Slow-release stress-resistant probiotic crystal ball and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112715948A (en) * 2020-12-17 2021-04-30 新希望乳业股份有限公司 High-activity probiotic crystal ball and preparation method and application thereof
CN113521110A (en) * 2021-07-12 2021-10-22 深圳零一生命科技有限责任公司 Slow-release stress-resistant probiotic crystal ball and preparation method thereof

Similar Documents

Publication Publication Date Title
AU2020101155A4 (en) Acid-resistant and sustained-release oral crystal ball containing probiotics
CN211658795U (en) Acid-resistant slow-release oral probiotic crystal ball structure
CN1684672B (en) Dosage form having an inner core and at least two coating layers
CN210844394U (en) Multi-layer coated crystal ball structure for oral probiotics
ES2500166T3 (en) Probiotic oral dosage forms
US20080181932A1 (en) Compositions for oral delivery of pharmaceuticals
CN213523777U (en) Acid-resistant slow-release oral probiotic crystal ball structure
AU770792B2 (en) Oral form of administration containing probiotic micro-organisms
CN102404990A (en) Prebiotic formulations and methods of use
CA3100445A1 (en) Acid-resistant and sustained-release oral crystal ball containing probiotics
KR20220020288A (en) Acid-resistant and sustained-release oral crystal ball containing probiotics
JP2010527712A (en) Magnetic device for obesity and method for manufacturing the same
US20240130977A1 (en) Orally available articles containing at least one stabilized supplement therein
TWM585623U (en) Multi-layered crystal ball encapsulation structure of oral probiotics
CN112121067A (en) Bifidobacterium infantis microcapsule and preparation method thereof
TWM559176U (en) Antioxidant active microcapsule structure using selenium complex to encapsulate lactobacillus
TWM611769U (en) Anti-acid sustained-release oral probiotic crystal ball structure
US20090023771A1 (en) Pharmaceutical composition comprising a proton pump inhibitor and protein component
JP3227150U (en) Acid-resistant and sustained-release oral probiotic spherical tablets
TWM597141U (en) Crystal ball structure of anti-acid sustained release oral probiotics
TWM611770U (en) Anti-acid sustained-release oral probiotic crystal ball structure
EP3691666B1 (en) A pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting
KR102464572B1 (en) Capsule of probiotics
TWM605965U (en) Granular structure for encapsulating probiotics
CN112312896A (en) Dosage forms comprising a living biotherapeutic product

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)